Literature DB >> 17215739

The potential utility of fibrin sealant dressing in repair of vascular injury in swine.

Bijan S Kheirabadi1, Eric M Acheson, Rodolfo Deguzman, Jacqueline M Crissey, Angel V Delgado, Scot J Estep, John B Holcomb.   

Abstract

BACKGROUND: A previous study in which fibrin sealant dressing (FSD) secured hemostasis in major arterial hemorrhage for 96 hours suggested the applicability of this dressing in damage control operations after severe trauma. The objective of this study was to determine the effective duration of FSD hemostatic function in vivo and to examine its potential utility for definitive repair of a major arterial injury in swine.
METHODS: High pressure bleeding in an infrarenal aortotomy was controlled by placing FSD on the wound with 4-minute compression (n = 15). If hemostasis was achieved, the abdominal cavity was closed. Surviving animals were killed at 2, 4, 6, and 8 weeks and aortotomy sites collected for histology.
RESULTS: FSD stopped arterial hemorrhage after 4-minute compression in 14 of 15 (93%) pigs. Dressings failed in two pigs at 36 and 53 minutes after treatment. Twelve (80%) animals recovered and resumed normal activities. Of the remaining 12, two developed rebleeding at the aortotomy site on days 8 and 11 and were killed; another was killed because of idiopathic low hematocrit on day 10. Nine pigs survived until scheduled to be killed, maintaining hemostasis with stable hematological values. In the surviving animals, serial computed tomography scans showed formation of a pseudoaneurysm at the aortotomy site, which resolved after 2 to 3 weeks. The initial vascular defect and pseudoaneurysm were filled with fibroblast-myoblast collagen rich tissues covered by endothelium.
CONCLUSION: FSD can seal an arterial injury, stop high pressure bleeding, and prevent rebleeding for at least 7 days. The dressing may be most beneficial in damage control operations. If combined with an elective interventional radiologic procedure (e.g. embolization or stenting), it may also offer an alternative to suture repair of vascular injuries in cases where profuse bleeding obstructs visualization.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17215739     DOI: 10.1097/01.ta.0000251595.45451.d0

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  7 in total

Review 1.  Topical and effective hemostatic medicines in the battlefield.

Authors:  Yin-Juan Zhang; Bo Gao; Xi-Wen Liu
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 2.  Current use of live tissue training in trauma: a descriptive systematic review.

Authors:  Luis Teodoro da Luz; Bartolomeu Nascimento; Homer Tien; Michael J Kim; Avery B Nathens; Savvas Vlachos; Elon Glassberg
Journal:  Can J Surg       Date:  2015-06       Impact factor: 2.089

3.  Atomic layer deposition of titanium dioxide on cellulose acetate for enhanced hemostasis.

Authors:  G Kevin Hyde; S Michael Stewart; Giovanna Scarel; Gregory N Parsons; Chun-Che Shih; Chun-Ming Shih; Shing-Jong Lin; Yea-Yang Su; Nancy A Monteiro-Riviere; Roger J Narayan
Journal:  Biotechnol J       Date:  2011-02       Impact factor: 4.677

Review 4.  Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding.

Authors:  DaShawn A Hickman; Christa L Pawlowski; Ujjal D S Sekhon; Joyann Marks; Anirban Sen Gupta
Journal:  Adv Mater       Date:  2017-11-22       Impact factor: 30.849

5.  Introduction of a potent single-donor fibrin glue for vascular anastomosis: An animal study.

Authors:  Mehdi Rasti Ardakani; Abdoljalil Kalantar Hormozi; Jalal Rasti Ardakani; Amir Hossein Davarpanahjazi; Ali Shayesteh Moghadam
Journal:  J Res Med Sci       Date:  2012-05       Impact factor: 1.852

6.  Enhanced hemostatic performance of tranexamic acid-loaded chitosan/alginate composite microparticles.

Authors:  Donghong Li; Pengxi Li; Jiatao Zang; Jiancang Liu
Journal:  J Biomed Biotechnol       Date:  2012-11-05

Review 7.  Hemostatic agents for prehospital hemorrhage control: a narrative review.

Authors:  Henry T Peng
Journal:  Mil Med Res       Date:  2020-03-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.